You have 9 free searches left this month | for more free features.

HMG Co A reductase

Showing 1 - 25 of 5,948

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immune-Mediated Necrotizing Myopathy Trial in Seattle (Gamunex-C, Albumin)

Withdrawn
  • Immune-Mediated Necrotizing Myopathy
  • Seattle, Washington
    University of Washington
Oct 19, 2022

Noonan Syndrome Trial in France (Simvastatin, Placebo)

Completed
  • Noonan Syndrome
  • Angers, France
  • +11 more
Nov 14, 2022

Hypercholesterolemia Trial (Ezetimibe, Simvastatin)

Completed
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia Trial (Ezetimibe, atorvastatin)

Completed
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease

Recruiting
  • Parkinson Disease
  • Dyskinesia, Drug-Induced
  • Intravenous Infusion
  • Portland, Oregon
  • +2 more
Dec 23, 2022

Sudden Sensorineural Hearing Loss Trial (Statin, methylprednisolone, dexamethasone)

Not yet recruiting
  • Sudden Sensorineural Hearing Loss
  • (no location specified)
Feb 2, 2023

HMG-CoA Reductase Inhibitor Toxicity Trial in Kansas City (Exercise)

Recruiting
  • HMG-CoA Reductase Inhibitor Toxicity
  • Exercise
  • Kansas City, Kansas
    University of Kansas Medical Center
Nov 16, 2021

Physical Activity Levels and Statin Therapy

Active, not recruiting
  • Cardiovascular Diseases
  • +2 more
  • Physical activity monitoring
  • Nijmegen, Netherlands
    Department of Physiology
Nov 15, 2022

Evaluate Effectiveness and Safety of Fresh or Frozen Embryo

Recruiting
  • Infertility, Female
  • Gyeonggi-do, Korea, Republic of
    CHA Fertility Hospital
Nov 17, 2021

Cardiovascular Drugs Adverse Reaction

Recruiting
  • Pharmacogenetics
  • +2 more
  • Oral Anticoagulant, Direct-Acting
  • Zagreb, Croatia
    UHC Zagreb
Mar 23, 2022

Hyperlipidemias Trial in Boston (Evolocumab, Statins (Cardiovascular Agents))

Recruiting
  • Hyperlipidemias
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 18, 2022

Prostate Cancer Metastatic Trial in Cairo (Rosuvastatin 20mg, surgical castration)

Completed
  • Prostate Cancer Metastatic
  • Rosuvastatin 20mg
  • surgical castration
  • Cairo, Egypt
    National Cancer Institute
Feb 25, 2021

Chronic Kidney Disease, Proteinuria Trial in Korea, Republic of (Telmisartan/Rosuvastatin 40/10mg, Telmisartan 40mg)

Unknown status
  • Chronic Kidney Disease
  • Proteinuria
  • Telmisartan/Rosuvastatin 40/10mg
  • Telmisartan 40mg
  • Wŏnju, Gangwon-do, Korea, Republic of
  • +15 more
Dec 11, 2020

Exercise-induced Muscle Damage in Statin Users

Completed
  • Cardiovascular Diseases
  • +2 more
  • Moderate-intensity exercise
  • Nijmegen, Netherlands
    Department of Physiology
Aug 23, 2021

Myocardial Infarction, Statin Adverse Reaction, HMG-CoA Reductase Inhibitor Toxicity Trial in Korea, Republic of (Rosuzet 10/5

Recruiting
  • Myocardial Infarction
  • +2 more
  • Ezetimibe 10mg + Rosuvastatin 5mg
  • Rosuvastatin 20mg
  • Bucheon, Gyeonggido, Korea, Republic of
  • +6 more
Sep 2, 2022

HMG-CoA Reductase Inhibitors on Meibomian Gland Morphology in

Completed
  • Meibomian Gland Dysfunction
  • +2 more
  • Keratograph 5M, Oculus, Wetzlar, Germany
  • Taipei, Taiwan
    National Taiwan University Hospital
Oct 12, 2020

Hyperlipidemias Trial in Seogu, Seoul, Seongnam-si (HMG-CoA Reductase Inhibitor, Probucol, Cilostazol)

Completed
  • Hyperlipidemias
  • HMG-CoA Reductase Inhibitor
  • +2 more
  • Seogu, Busan, Korea, Republic of
  • +4 more
Sep 18, 2019

Peripheral Arterial Disease Trial (Simvastatin, Losartan, Pioglitazone)

Completed
  • Peripheral Arterial Disease
  • (no location specified)
May 12, 2021

Breast Cancer Trial in Mansoura (Pitavastatin, )

Not yet recruiting
  • Breast Cancer
  • Mansoura, Egypt
    Faculty of pharmacy, Mansoura university
Jan 9, 2021

Endothelial Dysfunction

Unknown status
  • Endothelial Dysfunction
  • HMG-CoA Reductase Inhibitor
  • Kubang Kerian, Kelantan, Malaysia
    Universiti Sains Malaysia
Aug 15, 2020

Postoperative Atrial Fibrillation Trial (Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days

Recruiting
  • Postoperative Atrial Fibrillation
  • Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days postoperative
  • No-intervention.
  • Odense, Denmark
    Odense University Hospital
Sep 30, 2022

Hyperlipidemia, HIV Trial in New York (Pitavastatin, Darunavir, Ritonavir)

Completed
  • Hyperlipidemia
  • HIV
  • New York, New York
    Bellevue/NYU AIDS Clinical Trials Unit
Jul 22, 2020

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Detroit (Laboratory Biomarker

Active, not recruiting
  • Invasive Breast Carcinoma
  • +6 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Jun 17, 2022

Traumatic Brain Injury Trial (Simvastatin, Placebo drug)

Not yet recruiting
  • Traumatic Brain Injury
  • (no location specified)
Oct 6, 2022

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
  • HIV-1-infection
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Buffalo, New York
    Evergreen Health
Oct 28, 2022